BackAyala Pharmaceuticals Overview

Ayala Pharmaceuticals Selling, General & Admin

Selling, General & Admin expenses for AYLA.

Quarterly SG&A Expenses

$2.16M
↓ 3.75% YoY

As of Dec 31, 2022

Annual SG&A Expenses (TTM)

$9.74M
↑ 5.01% YoY

Trailing 12 months ending Dec 31, 2022

Average SG&A Expenses (Comparison Companies)

Selling, General & Admin History

Selling, General & Admin Comparison

Annual Selling, General & Admin Growth Rate (%)

Annual Selling, General & Admin Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin